HK Stock Market Move | XTALPI (02228) rose more than 7% after the performance report. The group achieved annual profits for the first time, and the Crystal Tai AI platform entered a period of value realization.

XTALPI (02228) rose more than 7% after the performance announcement. As of press time, it rose 5.62% to HK$9.59 with a turnover of HK$174 million. On the news front, XTALPI released its annual performance, with annual revenue reaching HK$803 million, a significant increase of 201.25% year-on-year. The net profit for the period was HK$135 million, turning losses into profits year-on-year, achieving annual profitability for the first time. The Group's first annual profit also made it the first Hong Kong-listed company in the AI for Science field to achieve profitability. Public information shows that in 2025, XTALPI continues to focus on "AI for Science". While the antibody business is growing rapidly, it has also successfully expanded into multi-modal innovative platforms such as peptides, molecular adhesives, and nucleic acids, driving the empowerment services and incubating innovations to gradually enter the validation phase. With multiple developments in its business, XTALPI is officially entering the phase of value realization of "hardcore innovation commercialization performance verification" by deepening the development of its "AI for Science" platform.